RTI Biologics, Inc. (NASDAQ:RTIX) delivered a profit and met Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company. Shares are up 6.46%.
RTI Biologics, Inc. Earnings Cheat Sheet
Results: Adjusted Earnings Per Share decreased 50% to $0.02 in the quarter versus EPS of $0.04 in the year-earlier quarter.
Revenue: Decreased 7.64% to $40.4 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: RTI Biologics, Inc. reported adjusted EPS income of $0.02 per share. By that measure, the company met the mean analyst estimate of $0.02. It beat the average revenue estimate of $38.76 million.
Quoting Management: “Our first quarter results were in line with our expectations,” said Brian K. Hutchison, president and chief executive officer of RTI. “In a very challenging environment, our distribution team has worked hard to respond to customer reaction to the FDA warning letter that was received in October 2012. International revenues continued to be negatively impacted by inaccuracies in European media coverage about the company and the tissue industry. We will continue to diligently work through these issues until we bring them to resolution.”
Key Stats (on next page)…
Revenue decreased 9.44% from $44.61 million in the previous quarter. EPS decreased 50% from $0.04 in the previous quarter.
Looking Forward: Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $0.06 to a profit $0.04. For the current year, the average estimate has moved down from a profit of $0.22 to a profit of $0.17 over the last ninety days.
Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)